U.S. federal trademark · Serial No. 98463858
Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Medical treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Scientific research in the nature of conducting clinical trials for others for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.